10/28/2025 | Press release | Archived content
October 28, 2025
We are pleased to serve as regulatory advisors in commercial due diligence for Andera Partners in its strategic investment in Adler Ortho, leading player in premium orthopedic implants and bioresorbable products.
Andera Partners is one of Europe's leading private capital firms headquartered in Paris, managing almost €5.0 billion in assets under management. Adler Ortho is an internationally renowned company based in Cormano (Milan) specializing in the design, production, and distribution of orthopedic implants, surgical instruments, and bioresorbable products, with strong focus on 3D-printed complex applications.
Providing regulatory guidance for Andera Partners' investment in Adler Ortho reinforced our role as a trusted advisor in the medical device sector. Our comprehensive due diligence-providing critical insights on EU MDR compliance, product certifications, and regulatory risk assessment-helped support an informed investment in this leading orthopedic innovation company."
Mercè Guerra Associate Director of Regulatory Affairs, Alira Health
This engagement underscores Alira Health's role as a trusted advisor to investors shaping the future of life sciences. Our work supports confident, growth-oriented decisions that help advance innovation across the healthcare sector. For more details, read the full press release on Andera Partners website . To learn more about Alira Health's Commercial Due Diligence services, visit www.alirahealth.com.